Impact Factor
4.63
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
28.99
1,933 total citations
h5-index
80
h5 depth signal
Cited share
94.3%
66 of 70
Total citations
1,933
Citation footprint
Metric signal
26.00
External metric anchor
Self-citation
0.3%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
200
United Kingdom
60
Australia
46
Italy
36
Canada
35
Citing Fields of Research
Endocrinology & Metabolism
181
Diabetes
114
Endocrine Therapy
72
Adrenal Dysfunction
46
Human Reproduction
33
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,269
Articles tracked across the journal lifetime
Indexed publication set
70
66 cited publications
Last 12 months
46
3.8 publications/month
Open access share
47.8%
22 OA publications in the last year
Leading citing country
United States
200 citing publications
Leading citing field
Endocrinology & Metabolism
181 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, winter 1980-
v1n1, winter 1980-
Active Coverage
Research Focus & Classification
Indexed Subjects
Endocrinology & Metabolism
Diabetes
Adrenal Dysfunction
Endocrine Therapy
Cytogenetics
Immunology
Issuing & Sponsoring Bodies
Contributor
Endocrine Society
Broad Categories
Endocrinology
Endocrinology & Metabolism
Adrenal Dysfunction
Diabetes
Endocrine Therapy
Osteopathies
Human Reproduction
MeSH Descriptors
Endocrinology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1210/endrev/bnag038
Open DOI
The Microbiome–Metabolokine–Adipokine Axis in Insulin Resistance: Adaptive and Maladaptive FGF21–GDF15 Signaling
Insulin resistance emerges from disturbances in interorgan metabolic communication in which nutrient exposure, microbial metabolism, and host endocrine responses interact across multiple metabolic compartments. This state-of-the-art revi...
02
DOI 10.1210/endrev/bnag036
Open DOI
Menopause-driven metabolomic shifts: unraveling cardiovascular disease risk in women
Menopause marks the end of a woman's reproductive life, and the transition to this stage is accompanied by profound physiological and metabolic changes. These include alterations in lipoproteins and various metabolites, such as lipids, f...
03
DOI 10.1210/endrev/bnag035
Open DOI
The sentinel hormone growth and differentiation factor-15, glucocorticoid homeostasis, and adrenal disorders
Growth and differentiation factor-15 (GDF-15) is a stress-responsive hormone secreted by various cell types in response to cellular stress. To regulate ingestive behavior, suppress food intake, and induce nausea and vomiting during cellu...
04
DOI 10.1210/endrev/bnag034
Open DOI
Decoding adrenal cellular heterogeneity in primary aldosteronism by single-cell analysis
Primary aldosteronism (PA), characterized by autonomous aldosterone excess, accounts for a substantial proportion of patients with hypertension, particularly those with resistant disease. Current clinical management is largely guided by ...
05
DOI 10.1210/endrev/bnag025
Open DOI
Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement
The medical management of obesity has been transformed by the introduction of obesity medicines (OMs), based on the actions of glucagon-like peptide-1 and other nutrient-stimulated hormones, enabling the achievement of unprecedented weig...
06
DOI 10.1210/endrev/bnag033
Open DOI
The evolution of new approaches to the treatment of congenital adrenal hyperplasia
Conventional management of classic congenital adrenal hyperplasia (CAH) relies on glucocorticoid (GC) therapy, both to replace the cortisol deficiency and to reduce the production of upstream cortisol precursors and subsequent metabolite...
07
DOI 10.1210/endrev/bnag032
Open DOI
Digestive hormones and their impact on bariatric and pharmacologic weight-loss therapies
Obesity is a growing global health challenge associated with major cardiometabolic complications. While bariatric surgery remains the most effective treatment for severe obesity, recent advances in incretin-based pharmacotherapy, multire...
08
DOI 10.1210/endrev/bnag012
Open DOI
In Memoriam: Delbert A. Fisher, 1928-2026
09
DOI 10.1210/endrev/bnag031
Open DOI
Correction to “Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement”
10
DOI 10.1210/endrev/bnag027
Open DOI
Safeguarding the development of offspring: the role of genetic integrity of the maternal germline
Human development begins with the fusion of sperm and oocyte, yet the maternal genome plays a far more active and essential role than traditionally appreciated. This review critically examines the influence of maternal genetic integrity ...
Bibliographical & Catalog Notes
Also issued online.
Vol. 16, no. 1 (1995)19950522 Notice not published Printed on acid-free paper